News
STVN
20.52
-1.16%
-0.24
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ascendis Pharma (ASND), Galapagos (GLPG) and Stevanato Group (STVN)
TipRanks · 3d ago
Weekly Report: what happened at STVN last week (1208-1212)?
Weekly Report · 3d ago
S&P 500 Futures Decline In Premarket Trading; Oracle, Stellantis Lag
Dow Jones · 12/11 12:31
Weekly Report: what happened at STVN last week (1201-1205)?
Weekly Report · 12/08 09:53
How Investors Are Reacting To Stevanato Group (STVN) Morgan Stanley’s New Hold Stance And Mixed Analyst Views
Simply Wall St · 12/08 09:19
Stevanato Group SpA Breaks Above 200-Day Moving Average - Bullish for STVN
NASDAQ · 12/03 21:42
Stevanato Group Price Target Cut to $24.00/Share From $26.00 by Morgan Stanley
Dow Jones · 12/02 18:06
Morgan Stanley Maintains Equal-Weight on Stevanato Group, Lowers Price Target to $24
Benzinga · 12/02 17:56
Stevanato Group assumed with an Equal Weight at Morgan Stanley
TipRanks · 12/01 21:35
Weekly Report: what happened at STVN last week (1124-1128)?
Weekly Report · 12/01 09:50
West Pharmaceutical: Back To Growth
Seeking Alpha · 12/01 08:54
Morgan Stanley Sticks to Their Hold Rating for Stevanato Group (STVN)
TipRanks · 11/24 13:25
Analysts Offer Insights on Healthcare Companies: Co-Diagnostics (CODX), Stevanato Group (STVN) and Alpha Cognition Inc (ACOG)
TipRanks · 11/24 11:30
Weekly Report: what happened at STVN last week (1117-1121)?
Weekly Report · 11/24 09:53
Can Stevanato Group's (STVN) Steady Guidance Sustain Investor Confidence Amid Industry Shifts?
Simply Wall St · 11/20 05:18
Stevanato Group Exceeds Q3 Expectations and Advances Key Projects
TipRanks · 11/18 21:30
Weekly Report: what happened at STVN last week (1110-1114)?
Weekly Report · 11/17 09:53
RSI Alert: Stevanato Group SpA (STVN) Now Oversold
NASDAQ · 11/14 21:31
Stevanato Group Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 11/11 17:06
Morgan Stanley Maintains Equal-Weight on Stevanato Group, Raises Price Target to $26
Benzinga · 11/11 16:56
More
Webull provides a variety of real-time STVN stock news. You can receive the latest news about Stevanato Group S P A through multiple platforms. This information may help you make smarter investment decisions.
About STVN
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.